InvestorsHub Logo
Followers 35
Posts 6308
Boards Moderated 0
Alias Born 02/09/2015

Re: None

Thursday, 02/26/2015 10:26:09 PM

Thursday, February 26, 2015 10:26:09 PM

Post# of 403742
More about Brilacidin.

OK recall the curve posted by ?sclimmuno- it showed what you would expect- big pharma pays more for drugs as they are farther along in trials.(duh) If CTIX has enough money for phase 3 why not hold out for more money from a big company? When they are further down the road, and not n the near future? Better for shareholders, ultimately , if they do.

More applications for Brilacidin- I do not have the ability to search prev posts- not a paying ihub customer. Has much been written about non cellulitis applications of the drug?

If not, I can try to add more- and I will gladly defer to any infectious disease docs who follow this board- are there any, by the way?

Any pt with pneumonia admitted to any US hospital who comes from a nursing center or rehab center must be covered for Gm positives, esp MRSA. ALWAYS two drugs, never one drug. Almost automatically this is Vancomycin(plus another antibiotic to cover gm - etc) Here is another potential big market for Brilacidin- so much simpler, as has been detailed, vs Vanco

Yes I am considering buying in a bit, but with 3 daughters in college(and another to come) little to invest. I am sure you know how it goes. Still shareless.